Cannabis Science Inc news

   Watch this stock
Showing stories 11 - 20 of about 82   

Articles published

CBIS 0.0600 0.0000 (0.00%)
price chart
Why Cannabis Science Inc (OTCMKTS:CBIS) Outstands among Marijuana Stocks?
Cannabis Science Inc (OTCMKTS:CBIS) is one pot stock that has been here from the beginning making several spectacular runs over the past several years.
Related articles »  
Where Cannabis Science Inc (OTCMKTS:CBIS) is Expected to find Support?
Cannabis Science Inc (OTCMKTS:CBIS) is one of the original Marijuana plays to hit the BB's back in 2009. Over the past several years as Marijuana stocks have heated up CBIS has been at the forefront of this incredible phenomenon trading massive volume ...
Cannabis Science, Inc. (OTCMKTS:CBIS) Surges On Sector Hype  HotStocked
Related articles »  
Cannabis Science (CBIS) Ready For A Prosperous And Healthy New Year: 'The ...
About Cannabis Science, Inc. Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory.
Cannabis Science Inc. (OTCMKTS:CBIS) To Pursue Cannabis Business ...  MMJ Observer
Related articles »  
Comprehensive Investigation Of Cannabis Science, A Recurrence Of Misleading ...
In the period between 1996 and 2009, the company that we now know as Cannabis Science operated business in a variety of industries under multiple aliases, "Patriot Holdings" in 1996, "National Healthcare Technology, Inc." in 1999, "Special Stone ...
Related articles »  
Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on ...
COLORADO SPRINGS, Colo., Aug. 22, 2014 /PRNewswire/ -- Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased to announce its sponsorship of UFCM ...
Related articles »  
Cannabis Science Inc (CBIS) news: Cannabis Science - Digging Deeper Into ...
Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development, proudly announces the submission of a patent application N2010968 in Europe entitled "Composition for the Treatment of Neurobehavioral Disorders.
Related articles »  
Cannabis Science, Inc. (CBIS) Signs Drug Development and Laboratory ...
COLORADO SPRINGS, Colo., Sept. 29, 2014 /PRNewswire/ -- Cannabis Science, Inc. (otcqb:CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, has entered into a laboratory services agreement with ...
Related articles »  
Cannabis Science, Inc. (CBIS) And Unistraw Holdings Join Forces To Produce ...
COLORADO SPRINGS, Colo., Sept. 16, 2014 /PRNewswire/ -- Cannabis Science, Inc. CBIS, +3.19% a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased to announce the signing of a ...
Related articles »  
Cannabis Science Inc (OTCMKTS:CBIS) Announces International Release Of 8 ...
Cannabis Science Inc (OTCMKTS:CBIS) made some big announcements during the first week of the year itself. Firstly, the company specializing in cannabis formulation-based drug development made public the Internation release of 8 of its initial products.
Cannabis Science, Inc. (OTCMKTS:CBIS) Grinds To A Halt
As usual, the global ascent didn't last very long, and when it turned sour CBIS was dragged down with the rest of the marijuana tickers. True, the crash isn't as bad as it could have been, but that's just because the ticker managed to recover some ...
Chad Steven Johnson Sells 1600000 Shares of Cannabis Science Stock (CBIS)  WKRB News
Cannabis Science COO Chad Steven Johnson Sells 1600000 Shares (CBIS)  Dakota Financial News